ArticleAdvances in therapy2023

Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China.

Xinhua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.